Disseminated cytomegalovirus disease after bendamustine: a case report and analysis of circulating B- and T-cell subsets

Disseminated cytomegalovirus disease after bendamustine: a case report and analysis of circulating B- and T-cell subsets

Abstract Background Bendamustine, used for the treatment of indolent B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia, is known to cause prolonged myelosuppression and lymphocytopenia and has been associated with the risk of developing serious and fatal infections. While reports of local...

Full description

Bibliographic Details
Main Authors: Andrea Cona, Daniele Tesoro, Margherita Chiamenti, Esther Merlini, Daris Ferrari, Antonio Marti, Carla Codecà, Giuseppe Ancona, Camilla Tincati, Antonella d’Arminio Monforte, Giulia Marchetti
Format: Article
Language:English
Published: BMC 2019-10-01
Series:BMC Infectious Diseases
Subjects:
Bendamustine
Disseminated CMV
Lymphoma
B-cells
T-cells
Online Access:http://link.springer.com/article/10.1186/s12879-019-4545-7

Internet

http://link.springer.com/article/10.1186/s12879-019-4545-7

Similar Items